Project Grant R01DA063199

Award Date 7/15/25
Completion Date 3/31/30
Dollars Obligated $655K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Tennessee, USA
Similar Awards
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to examine the link between epigenetic processes, mitochondrial function, and drug-seeking behavior in the context of nicotine use disorder. The award, totaling $169,474.00 and spanning August 2024 to July 2029, will be carried out by researchers at the University of Maryland, Baltimore. The key objectives of this research...
This Project Grant award of $1,315,596.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to understand the effects of maternal exposure to electronic nicotine delivery system (ENDS) aerosols during pregnancy on addiction-related behaviors and neurocircuitry in offspring. The project, which runs from March 2025 to December 2029, will use animal models to examine the impacts of prenatal ENDS exposure on...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund research to study the neurogenetic mechanisms underlying nicotine and cannabis addiction. The $175,888 award, effective September 1, 2024 through August 31, 2028, will enable the development of novel transcriptome-connectome analysis methods to identify genes associated with changes in brain functional connectivity related to addiction. The...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 Drug Use and Addiction Research Programs, will provide $166,375 to The University of Kentucky Research Foundation to examine the role of nicotine use in exacerbating neuroimmune consequences of HIV using a rat model. The research aims to evaluate the impact of chronic nicotine self-administration on cognitive function, anxiety-like behavior, and neuroimmune signaling in brain regions associated...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $379,348 to Vanderbilt University to investigate the role of ovarian hormones in regulating dopamine-acetylcholine interactions in the nucleus accumbens and their influence on nicotine addiction. The 18-month project aims to define the estrogen receptor subtypes contributing to these effects, determine how estrogen receptors regulate...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to develop a translational rat model of the neonatal intensive care unit (NICU) experience and its impacts on substance use disorder risk. The $368,315 award to the Georgia State University Research Foundation will: 1) design and test a model combining early pain, resource scarcity, and separation from caregivers to mimic key aspects of...
This Project Grant award of $2,594,198.00 from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports research to elucidate the neural circuitry linked to smoking and the genetic influences on it. The study will use the UK Biobank neuroimaging dataset to examine habenula functional connectivity with the salience network and ventral tegmental area, and the influence of genomic variations on this connectivity. It will compare...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
This Project Grant award of $847,000 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to evaluate the therapeutic potential of neuropeptide S receptor 1 (NPSR1) agonism for reducing opioid self-administration and relapse in preclinical animal models. The research team at the University of Tennessee Health Science Center will leverage pharmacological tools to investigate NPSR1 as a novel target for treating...
This $2,419,326 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a longitudinal study to investigate neurobehavioral and psychosocial predictors of health risk behaviors (HRBs) in adolescence and young adulthood. The primary awardee, Virginia Polytechnic Institute & State University, will conduct assessments over 15 years to understand brain development and its impact on substance use and...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $654,500.00 to the University of Tennessee Health Science Center to conduct research on the social factors that influence the initiation and continuation of nicotine addiction.

The key research objectives are to investigate how social learning alters the hedonic value of nicotine and facilitates the extinction of nicotine-conditioned aversion, with a focus on the roles of the CACNA1C gene and oxytocin receptor signaling in the central amygdala. The project employs a rodent model called socially acquired nicotine intravenous self-administration (SANSA) to simulate the initial negative experience of voluntary nicotine exposure in adolescents and study the influence of social factors on continued nicotine intake. The research findings are expected to enhance the understanding of smoking initiation and provide insights into the processes by which the social environment influences the trajectory of substance use disorders.

Generated 8/5/25, 3:00 AM